Lv12
10 积分 2026-01-12 加入
LBA66 Afatinib versus chemotherapy for treatment-naïve non-small cell lung cancer with a sensitizing uncommon epidermal growth factor receptor mutation: A phase III study (ACHILLES/TORG1834)
1小时前
求助中
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
1小时前
已完结
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
1小时前
已完结
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
1天前
已完结
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
12天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
12天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
12天前
已完结
皖公网安备34019202002308
